Beyond the year 2000 in CHD research: current understanding of the cellular mechanism of atherosclerosis.
Stanton
E
E
St Joseph's Hospital, Hamilton, Canada.
D000975:Antioxidants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002170:Canada; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000378:metabolism* / Q000517:prevention & control; D018450:Disease Progression; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism*; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D018945:Monocyte Chemoattractant Proteins / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*
D000975:Antioxidants; D002121:Calcium Channel Blockers; D015815:Cell Adhesion Molecules; D018945:Monocyte Chemoattractant Proteins